Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528690) titled 'Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: VA Office of Research and Development

Condition: Hepatic Encephalopathy Cirrhosis

Intervention: Biological: Microbiota transplant therapy (MTT) capsules

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 30, 2026

Target Sample Size: 162

Countries of Recruitm...